A new Cell Division study reports that linalool stabilizes the NR3C2 protein in gastric cancer cells, activating NFKBIZ and ...
Researchers report that the adipogenesis-related gene CEBPD is downregulated in breast tumors, serves as an independent ...
Many cancer treatments work by exploiting weaknesses in tumor cells, overwhelming their ability to survive, repair damage or ...
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine ...
High-grade serous ovarian cancer is an aggressive form of ovarian cancer, characterized in particular by high diversity among ...
Cancer cells that have lost one safeguard against DNA damage can become dependent on another, an enzyme called Wee1. Drugs ...
Cancer treatment pioneer Dennis Slamon received Albany Prize for breakthrough breast cancer research that transformed ...
Novocure (Nasdaq: NVCR) announced today that it has entered into a clinical trial collaboration and supply agreement with Verastem Oncology to evaluate the use of Novocure’s Tumor Treating Fields ...
A previously unknown mechanism required for cells to start proliferating has been identified. A combination of mathematical modelling and cell-based experiments shows that the enzyme WEE1 switches off ...
Researchers at the Nano Life Science Institute (WPI-NanoLSI) at Kanazawa University have discovered that tiny structural ...
Colorectal cancer rates are rising across younger and older age groups, according to a study published in NEJM Evidence.